Claire Tridon is an Investigator Formulation Scientist in Global Formulation, based within Pharmaceutical Development at GlaxoSmithKline, Harlow.
Claire completed a Master degree at the Conservatoire National des Arts et Metiers, Paris, France, in 2005. During her Master, Claire developed a new patentable polymeric strip drug product and worked at Schering-Plough, Segre, France where she optimised the efficiency (cycle time and yield) of the manufacturing process of a commercial injectable antibiotic cream. Following this, she joined GlaxoSmithKline Production at Mayenne, France where she gained experience in trouble shooting and optimising the commercial process and formulation of solid dosage forms (sachets, tablets, powders for oral suspensions). In 2006, she joined GlaxoSmithKline R&D where she developed bio-enhanced formulations and led the development of continuous processes (roller compaction and twin screw granulation). Her experience and interests include developing understanding of pharmaceutical continuous processes using PAT, multivariate analysis, mechanistic modelling and simulation. At GlaxoSmithKline, Claire also gained extensive experience in transferring late stage drug products from R&D to continuous and semi-continuous platforms at commercial sites. Her experience in technology transfers also includes performing risks assessments; developing and implementing design space and control strategy to ensure drug product robustness and Quality by Design.